Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

324
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
324
Analgesia and Pain Management01:25

Analgesia and Pain Management

463
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
463
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

56
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
56
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
147
Cancer Therapies02:49

Cancer Therapies

7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

200
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
200

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adaptive Admittance Control for Robotic Ultrasound Examination Based on a Breast Biomechanical Model.

The international journal of medical robotics + computer assisted surgery : MRCAS·2026
Same author

GC<sup>2</sup>MFND: Multi-Granularity Conflict and Domain-Guided Calibration for Multimodal Fake News Detection.

Entropy (Basel, Switzerland)·2026
Same author

Cooperative chelation for high-performance Perovskite light-emitting diodes.

Nature communications·2026
Same author

Chinese expert consensus: Radioactive iodine-125 seed interstitial brachytherapy for retroperitoneal lymph node metastases (2024 edition).

Journal of cancer research and therapeutics·2026
Same author

Complement factor B deficiency promotes lung cancer progression via FOS-mediated tryptophan metabolism and immune suppression.

Communications medicine·2026
Same author

Ultrathin Quasi-2D Perovskite-Organic Segregated-Structure Coupling for High-Performance Narrowband Photomultiplication Detectors.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Related Experiment Video

Updated: May 30, 2025

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

12.6K

Implementing Cancer Pain Management Training for Pharmacists Using the Kirkpatrick Evaluation Model.

Yu Liu1, Yang Peng2, Bimin Zhu2

  • 1Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China.

Journal of Pain Research
|January 27, 2025
PubMed
Summary

This study developed and evaluated a cancer pain management training program for pharmacists. The program effectively enhanced pharmacists' knowledge and skills, as evidenced by significant improvements in learning, behavior, and practice.

Keywords:
Kirkpatrick four-tier evaluation modelcancer pain managementcontinuing educationevaluation of training effectivenesspharmacist

More Related Videos

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
07:14

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery

Published on: January 18, 2018

9.2K
Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training
05:04

Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training

Published on: August 9, 2024

849

Related Experiment Videos

Last Updated: May 30, 2025

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

12.6K
A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
07:14

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery

Published on: January 18, 2018

9.2K
Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training
05:04

Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training

Published on: August 9, 2024

849

Area of Science:

  • Pharmacology and Pharmaceutical Sciences
  • Medical Education
  • Oncology

Background:

  • Effective cancer pain management is crucial for improving patient quality of life.
  • Pharmacists play a vital role in optimizing pain management strategies.
  • A need exists for structured training programs to enhance pharmacists' expertise in cancer pain management.

Purpose of the Study:

  • To develop a comprehensive training program focused on cancer pain management for pharmacists.
  • To evaluate the effectiveness of this training program using a multi-tiered approach.

Main Methods:

  • A well-structured curriculum was developed incorporating mentoring, study groups, and problem-based learning.
  • The Kirkpatrick four-tier evaluation model (reaction, learning, behavior, results) was employed.
  • Fifty-three pharmacists participated in the training and subsequent evaluations.

Main Results:

  • Over 85% of participants reported satisfaction with the training.
  • A statistically significant improvement in knowledge was observed, with accurate responses increasing from 57.7% to 64.2% (p=0.014).
  • 86.8% of trainees met behavioral benchmarks, with high engagement in multidisciplinary teams and consultations.

Conclusions:

  • The training program was effective across all Kirkpatrick model dimensions.
  • The program significantly enhanced pharmacists' comprehension and proficiency in cancer pain management.
  • This initiative demonstrates a successful model for professional development in specialized areas of pharmacy practice.